FLT3D835Y/F691L-IN-1
Selected Variant
T209898-01
Size: 10 mg
Product Specifications
Target
FLT
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
FLT3D835Y/F691L-IN-1 (compd 8v) is an orally active inhibitor targeting the secondary mutations D835Y/F691L in the FLT3 tyrosine kinase domain, with IC50 values of 1.5 and 9.7 nM, respectively. This compound is applicable in research related to acute myeloid leukemia.
Molecular Formula
C26H37N7O4
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940833-100 1x 100 µL
Calponin-1 (CALP + CNN1/832), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PB9354-Dylight594 100 µg
Anti-alpha 1 Antitrypsin/SERPINA1 Antibody Picoband® (Dylight594 Conjugate)
Sign In for Pricing
View Details 
BNC402353-500 1x 500 µL
Calcineurin A / PPP3CA (CALNA/2353), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041953-500 1x 500 µL
CD21 (Mature B-Cell & Follicular Dendritic Cell Marker) (CR2/1953), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 